Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies

J Neurol Sci. 1993 Dec 15;120(2):174-9. doi: 10.1016/0022-510x(93)90270-9.

Abstract

A point mutation of mitochondrial tRNALeu(UUR) gene is responsible for a MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) subgroup of mitochondrial encephalomyopathies. In most cases, the mutant mitochondrial DNA (mtDNA) coexists with normal mtDNA in a heteroplasmic manner. In order to quantify the content of mutant mtDNA, we developed a quantitative method of PCR. Using this method, the distribution of the mutant mtDNA was examined in 32 different tissues among 18 autopsied organs from a patient with MELAS, who had shown hypophyseal dysfunction. The percentage of the mutant mtDNA at nucleotide number 3243 in each tissue was ranged between 22% and 95%. The content of the mutant mtDNA was at the highest (95%) in the hypophysis and higher in the cerebral cortex than in the white matter. This study shows a possible correlation of tissue dysfunction with accumulation of the mutant mtDNA within the brain.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoradiography
  • Brain Chemistry / physiology
  • DNA, Mitochondrial / genetics*
  • Female
  • Humans
  • MELAS Syndrome / genetics
  • MELAS Syndrome / metabolism*
  • MELAS Syndrome / physiopathology
  • Pituitary Function Tests
  • Pituitary Gland, Posterior / physiology
  • Pituitary Hormones, Posterior / blood
  • Point Mutation*
  • Polymerase Chain Reaction

Substances

  • DNA, Mitochondrial
  • Pituitary Hormones, Posterior